Make Better Decisions - Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

Get the Book: Make Better Decisions

Finding and Evaluating Generic and Branded Drug Market Entry Opportunities

PDF eBook: Just $10 Get Print Book on Amazon

Serving leading biopharmaceutical companies globally:

Boehringer Ingelheim
AstraZeneca
Harvard Business School
McKesson
McKinsey
Johnson and Johnson

Last Updated: December 6, 2019

DrugPatentWatch Database Preview

PROPRANOLOL HYDROCHLORIDE Drug Profile

See Plans and Pricing

« Back to Dashboard

When do Propranolol Hydrochloride patents expire, and when can generic versions of Propranolol Hydrochloride launch?

Propranolol Hydrochloride is a drug marketed by Actavis Elizabeth, Adare Pharms Inc, Inwood Labs, Mylan, Nortec Dev Assoc, Upsher Smith Labs, Zydus Pharms Usa Inc, Athenex Inc, Baxter Hlthcare Corp, Fosun Pharma, Fresenius Kabi Usa, Hikma Farmaceutica, Smith And Nephew, Solopak, Morton Grove, West-ward Pharms Int, Ani Pharms Inc, Dava Pharms Inc, Duramed Pharms Barr, Impax Labs Inc, Innogenix, Interpharm, Ipca Labs Ltd, Ivax Sub Teva Pharms, Lederle, Northstar Hlthcare, Par Pharm, Purepac Pharm, Roxane, Sandoz, Schering, Superpharm, Teva, Vintage Pharms, Warner Chilcott, Watson Labs, Watson Labs Teva, and Yaopharma Co Ltd. and is included in one hundred and thirty-nine NDAs.

The generic ingredient in PROPRANOLOL HYDROCHLORIDE is hydrochlorothiazide; propranolol hydrochloride. There are thirty-two drug master file entries for this compound. One supplier is listed for this compound. Additional details are available on the hydrochlorothiazide; propranolol hydrochloride profile page.

Drug patent expirations by year for PROPRANOLOL HYDROCHLORIDE
Recent Clinical Trials for PROPRANOLOL HYDROCHLORIDE

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University Hospital, BordeauxPhase 3
AMRO-HHT-France - Association Maladie de Rendu-OslerPhase 3
Xiangya Hospital of Central South UniversityPhase 2

See all PROPRANOLOL HYDROCHLORIDE clinical trials

Recent Litigation for PROPRANOLOL HYDROCHLORIDE

Identify potential future generic entrants

District Court Litigation
Case NameDate
Salix Pharmaceuticals, Inc. v. Teva Pharmaceuticals USA, Inc.2017-03-27
Wyeth v. Biovail Corporation2008-06-26
Plaintiff(s) v. Defendant(s)2008-01-31

See all PROPRANOLOL HYDROCHLORIDE litigation

Pharmacology for PROPRANOLOL HYDROCHLORIDE
Medical Subject Heading (MeSH) Categories for PROPRANOLOL HYDROCHLORIDE
Synonyms for PROPRANOLOL HYDROCHLORIDE
( inverted question mark)-1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride
( inverted question mark)-Propranolol hydrochloride
(??)-Propranolol HCl
(?)-Propranolol hydrochloride
(+-)-1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride
(+/-)-[2-Hydroxy-3-(naphthyloxy)propyl]isopropylammonium chloride
(+/-)-1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol, HCl
(+/-)-1-Isopropylamino-3-(1-naphthyloxy)-2-propanol hydrochloride
(+/-)-Propranolol hydrochloride
(+/-)-Propranolol hydrochloride, >=99% (TLC), powder
(+/-)-Propranolol hydrochloride, analytical reference material
(+/-)-Propranolol, Hydrochloride
(2-Hydroxy-3-(naphthyloxy)propyl)isopropylammonium chloride
(R)-Propranolol hydrochloride
(RS)-1-[(1-Methylethyl)amino]-3-(1-naphthalenyloxy)-2-propanol hydrochloride
(y)-Propranolol hydrochloride
1-(1-Naphthyloxy)-2-hydroxy-3-(isopropylamino)propane hydrochloride
1-(1-Naphthyloxy)-2-hydroxy-3-isopropylaminopropane hydrochloride
1-(1-naphthyloxy)-2-hydroxy-3-isopropylaminopropanehydrochloride
1-(alpha-naphthoxy)-3-(iso-propylamino)-2-propanol hydrochloride
1-(alpha-naphthoxy)-3-(isopropylamino)-2-propanol hydrochloride
1-(Isopropylamino)-3-(.alpha.-naphthoxy)-2-propanol hydrochloride
1-(Isopropylamino)-3-(1-naphthoxy)-propan-2-ol hydrochloride
1-(Isopropylamino)-3-(1-naphthyloxy)-2-propanol hydrochloride
1-(Isopropylamino)-3-(1-naphthyloxy)propan-2-ol hydrochloride
1-(Isopropylamino)-3-(1-napthyloxy)-2-propanol hydrochloride
1-(Isopropylamino)-3-(alpha-naphthoxy)-2-propanol hydrochloride
1-(Isopropylamino)-3-(naphthalen-1-yloxy)propan-2-ol hydrochloride
1-(naphthalen-1-yloxy)-3-[(propan-2-yl)amino]propan-2-ol hydrochloride
1-[(1-methylethyl)amino]-3-(naphthalen-1-yloxy)propan-2-ol hydrochloride
1-[(methylethyl)amino]-3-naphthyloxypropan-2-ol, chloride
1-Isopropylamino-3-(1-naphthoxy)-propan-2-ol-hydrochloride
1-Isopropylamino-3-(1-naphthyloxy)-2-propanol hydrochloride
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol hydrochloride
1-naphthalen-1-yloxy-3-(propan-2-ylamino)propan-2-ol;hydrochloride
146874-86-4
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, hydrochloride
2-Propanol, 1-((1-methylethyl)amino)-3-(1-naphthalenyloxy)-, hydrochloride, (+-)-
2-Propanol, 1-(isopropylamino)-3-(1-naphthyloxy)-, hydrochloride
2-Propanol, 1-(isopropylamino)-3-(1-naphthyloxy)-, hydrochloride, (+-)-
3-[(methylethyl)amino]-1-naphthyloxypropan-2-ol, chloride
318-98-9
3506-09-0
4289AB
AB0011639
AC1L1XZ4
Acifol
ACM318989
ACT02695
AKOS005267141
AN-23392
Anaprilin
Anapriline
Angilol
ANW-62232
Apsolol
Arcablock
ARONIS24408
Artensol
Avlocardyl
AX8233861
AY 64043
AY-64043
BBC/572
BCP15350
Beprane
Berkolol
Beta Neg
beta-NEG
Beta-Tablinen
Beta-Timelets
BG0302
BIM-0050871.0001
Biocard
Blocaryl
C-4618
C16H21NO2.HCl
C16H22ClNO2
Cardinol
Caridolol
CAS-318-98-9
CC-33976
CCG-39239
CCG-39447
CCRIS 1105
CHEBI:8500
CHEMBL1671
CHM0004159
Cinlol
Ciplar
Corbeta
CPD000059167
CS-2680
CTK3J2636
d,l-Propranolol hydrochloride
D00483
Deralin
Detensol
Dibudinate
DL-Anapriline
DL-Propranolol hydrochloride
DL-Propranolol hydrochloride, 99%
Dociton
DSSTox_CID_1198
DSSTox_GSID_21198
DSSTox_RID_76007
DTXSID3021198
Dumopranol
Duranol
Efectolol
Efektolol
EINECS 206-268-7
EINECS 222-501-5
Elbrol
Emforal
EU-0100896
EUR-1000
Farprolol
Frekven
FT-0603377
FT-0635178
GP3553
Half-Inderal
Hemangeol
Hemipralon
Herzbase
Herzul
HMS1570P06
HMS1571G12
HMS1571I04
HMS1922P19
HSDB 3176
HY-B0573
I 2065
I14-2718
ICI 45520
ICI-45520
Ikopal
IN1139
Inderal
Inderal (TN)
Inderal hydrochloride
Inderal La
Inderalici
Inderex
Indermigran
Inderol
Indobloc
Innopran
InnoPran XL
Innopran XL (TN)
J10004
Jsp005924
KB-215769
KDM-1102
Kemi
Kidoral
KS-00000V0D
KS-1097
LP00896
LS-7676
MCULE-6124856976
MFCD00012558
Migrastat
MLS000859628
MLS001055449
MLS001056753
MLS002222321
MLS002548855
MolPort-001-759-087
Naprilin
NC00687
NCGC00024690-04
NCGC00091932-01
NCGC00094212-01
NCGC00094212-02
NCGC00094212-03
NCGC00094212-04
NCGC00094212-05
NCGC00256554-01
NCGC00259435-01
NCGC00261581-01
Nedis
Nelderal
Noloten
Novopranol
NSC 91523
NSC-758950
NSC-91523
NSC758950
NSC91523
Obsidan
Oposim
P 0884
P0995
Panolol
Pharmakon1600-01505270
Prandol
Pranix
Prano-Puren
Pranolol
Proberta LA
Procor
Pronovan
Propabloc
Propadex
Propalong
Propanolol hydrochloride
Propayerst
Prophylux
propra vt ct
Proprahexal
Propral
propranolol (hydrochloride)
Propranolol chloride
Propranolol Hcl
Propranolol Hcl Intensol
PROPRANOLOL HYDROCHLORIDE (+/-)
Propranolol hydrochloride (JP17/USP)
Propranolol hydrochloride [USAN:JAN]
Propranolol hydrochloride [USAN:USP:JAN]
Propranolol Hydrochloride 1.0 mg/ml in Methanol (as free base)
Propranolol hydrochloride for performance test, European Pharmacopoeia (EP) Reference Standard
Propranolol hydrochloride intensol
Propranolol hydrochloride solution, 1.0 mg/mL in methanol (as free base), ampule of 1 mL, certified reference material
Propranolol hydrochloride, 99%
Propranolol hydrochloride, European Pharmacopoeia (EP) Reference Standard
Propranolol hydrochloride, Pharmaceutical Secondary Standard; Certified Reference Material
Propranolol hydrochloride, United States Pharmacopeia (USP) Reference Standard
Propranolol.HCl
PROPRANOLOLHYDROCHLORIDE
Propranolon hydrochloride
Propranovitan
Propranur
Propraratiopharm
Prosin
Pur-Bloka
Pylapron
Q-201632
R+C5989educor
Rapynogen
Relax-B
RTR-013480
s4076
Sagittol
SAM002264638
SAM002699889
Sawatol
SBB080817
SC-15116
Scandrug
SCHEMBL41688
Sinal
Sloprolol
SMR000059167
SPECTRUM1505270
SR-01000075285
SR-01000075285-1
SR-01000075285-3
ST50319806
Sudenol
SW219414-1
Tensiflex
Tesnol
Tev-Tropin
Tiperal
TL8002432
Tonum
Tox21_201886
Tox21_302905
Tox21_500896
TR-013480
W-109142
WLN: L66J BO1YQ1MY1 & 1 & GH
Z90121066
ZMRUPTIKESYGQW-UHFFFAOYSA-N
ZX-AS004773
Paragraph IV (Patent) Challenges for PROPRANOLOL HYDROCHLORIDE
Tradename Dosage Ingredient NDA Submissiondate
INDERAL LA CAPSULE, EXTENDED RELEASE;ORAL propranolol hydrochloride 018553

US Patents and Regulatory Information for PROPRANOLOL HYDROCHLORIDE

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Ipca Labs Ltd PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 078955-004 Jun 2, 2008 AB RX No No   Start Trial   Start Trial   Start Trial
Roxane PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 070517-001 Jul 7, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride TABLET;ORAL 071791-001 Jul 15, 1987 DISCN No No   Start Trial   Start Trial   Start Trial
Fresenius Kabi Usa PROPRANOLOL HYDROCHLORIDE propranolol hydrochloride INJECTABLE;INJECTION 075826-001 Aug 31, 2001 AP RX No No   Start Trial   Start Trial   Start Trial
Ani Pharms Inc PROPRANOLOL HYDROCHLORIDE AND HYDROCHLOROTHIAZIDE hydrochlorothiazide; propranolol hydrochloride TABLET;ORAL 070705-001 Oct 1, 1986 DISCN No No   Start Trial   Start Trial   Start Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Moodys
Medtronic
Dow
Mallinckrodt
Johnson and Johnson
Merck

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.